You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2018-03-12 1 infringement of U.S. Patent Nos. 6,174,442 (“the ’442 patent”) and 9,561,251 (“the ’251 patent”) (collectively…On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled “Pharmaceutical compositions.… THE PATENTS-IN-SUIT 7. On January 16, 2001, the United States Patent and Trademark…Switzerland is the assignee of the ’442 patent. A copy of the ’442 patent is attached hereto as Exhibit A. …is the assignee of the ’251 patent. A copy of the ’251 patent is attached hereto as Exhibit B. External link to document
2019-09-11 117 Complaint - Amended THE ’251 PATENT 7. On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled…This is an action for infringement of U.S. Patent No. 9,561,251 as corrected by the Certificate of Correction… of Correction regarding the ’251 patent. A copy of the ’251 patent, as corrected by the Certificate … in prior patent cases. On information and belief, Lupin Atlantis has been sued for patent infringement… ) FIRST AMENDED COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Vifor Fresenius External link to document
2020-08-13 256 Order - -Memorandum and Order claims 29, 30, 31 and 51 of U.S. Patent No. 9,561,251 (“the ’251 patent”). In connection with narrowing…this 13th day of August 2020: This is a patent case brought by Plaintiffs Vifor Fresenius Medical…aware of when he submitted a declaration to the Patent Office in 2015. (D.I. 216 at 8-10). Defendants…signed and submitted his sworn declarations” to the Patent Office. (D.I. 225 at 5 (emphasis in original)).…2018 2 September 2022 1:18-cv-00390 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.